Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G



Comment for Type of Reporting Person:  Based on 3,168,590 Class A Ordinary Shares ("Class A Shares"), consisting of 2,890,756 Class A Shares outstanding as reported by Mobile-health Network Solutions (the "Issuer") on March 17, 2025, and an additional 277,834 Class A Shares that the reporting person has the right to acquire pursuant to the Standby Equity Purchase Agreement ("SEPA") entered into on February 14, 2025 by YA II PN, Ltd. ("YA II") with the Issuer. Under the SEPA, the Issuer has the option to sell up to $10 million of its Class A Shares to YA II, and YA II is obligated to purchase such shares, at a price and on the terms and subject to the conditions set forth in the SEPA. Under the SEPA, the Issuer is prohibited from issuing and selling Class A Shares to YA II to the extent that it would cause the aggregate number of Class A Shares beneficially owned by YA II and its affiliates to exceed 9.99% of the then outstanding Class A Shares of the Issuer.


SCHEDULE 13G


 
YA II PN, Ltd.
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
YA Global Investments II (U.S.), LP
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
Yorkville Advisors Global, LP
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
Yorkville Advisors Global II, LLC
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
YAII GP, LP
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
YAII GP II, LLC
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
 
Mark Angelo
 
Signature:/s/ Mark Angelo
Name/Title:Mark Angelo
Date:04/01/2025
 
SC-Sigma Global Partners, LP
 
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:04/01/2025
primary_doc.xml